Improvements in Atopic Dermatitis from Ruxolitinib Treatment

This new post-hoc analysis of ruxolitinib cream for those with eczema indicates that continued treatment past 8 weeks may lead to further benefit for those with the skin disease.

Related Keywords

Oregon , United States , Ericl Simpson , Eric Simpson , Oregon Health Science University In Portland , Global Assessment , Oregon Health , Science University , Itch Numerical Rating Scale , Eczema Area , Severity Index , Dermatology Life Quality Index , Atopic Dermatitis , Sad , Eczema , Ruxolitinib ,